Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sung Hee Lim

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
World Journal of Gastroenterology|February 17, 2015
Retrospective analysis of extra-gastrointestinal stromal tumorsJun Ho Yi, Byeong-Bae Park, Jung Hun Kang, et al.
Journal of Korean Medical Science|April 4, 2023
Effects of Omicron Infection and Changes in Serum Antibody Response to Wild-Type, Delta, and Omicron After a Booster Dose With BNT163b2 Vaccine in Korean Healthcare WorkersSung Hee Lim, Han Jo Kim, Se Hyung Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non-Small Cell Lung CancerHaa-Na Song, Ki Sun Jung, Kwai Han Yoo, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Differential T cell clonal dynamics underlie outcomes to frontline chemoimmunotherapy in advanced gastric cancerSamuel J Wright, Sarah Kang, Minae An, et al.
Cell Reports. Medicine|July 2, 2026
Differential T cell clonal dynamics underlie outcomes to frontline chemoimmunotherapy in advanced gastric cancerSamuel J Wright, Sarah Kang, Minae An, et al.
Cancer Research and Treatment|January 6, 2017
Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid CancerMin-Young Lee, Bo Mi Ku, Hae Su Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2019
Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)Jang Ho Cho, Sung Hee Lim, Ho Jung An, et al.
Cancer Research and Treatment|January 28, 2015
Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast CancerJi Yun Lee, Sung Hee Lim, Min-Young Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2015
A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or ErlotinibJi Yun Lee, Jong-Mu Sun, Sung Hee Lim, et al.
Yonsei Medical Journal|July 23, 2021
Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II TrialSung Hee Lim, Jina Yun, Min Young Lee, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
World Journal of Gastroenterology|February 17, 2015
Retrospective analysis of extra-gastrointestinal stromal tumorsJun Ho Yi, Byeong-Bae Park, Jung Hun Kang, et al.
Journal of Korean Medical Science|April 4, 2023
Effects of Omicron Infection and Changes in Serum Antibody Response to Wild-Type, Delta, and Omicron After a Booster Dose With BNT163b2 Vaccine in Korean Healthcare WorkersSung Hee Lim, Han Jo Kim, Se Hyung Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non-Small Cell Lung CancerHaa-Na Song, Ki Sun Jung, Kwai Han Yoo, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Differential T cell clonal dynamics underlie outcomes to frontline chemoimmunotherapy in advanced gastric cancerSamuel J Wright, Sarah Kang, Minae An, et al.
Cell Reports. Medicine|July 2, 2026
Differential T cell clonal dynamics underlie outcomes to frontline chemoimmunotherapy in advanced gastric cancerSamuel J Wright, Sarah Kang, Minae An, et al.
Cancer Research and Treatment|January 6, 2017
Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid CancerMin-Young Lee, Bo Mi Ku, Hae Su Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2019
Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)Jang Ho Cho, Sung Hee Lim, Ho Jung An, et al.
Cancer Research and Treatment|January 28, 2015
Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast CancerJi Yun Lee, Sung Hee Lim, Min-Young Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2015
A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or ErlotinibJi Yun Lee, Jong-Mu Sun, Sung Hee Lim, et al.
Yonsei Medical Journal|July 23, 2021
Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II TrialSung Hee Lim, Jina Yun, Min Young Lee, et al.
Pageof 11